Table 1.
Patient and treatment characteristics
| Patient | Age (yr) | Primary tumor | Concomitant treatment | Gastroduodenal artery embolization | Site of injection | Gastrointestinal activity on 99Tcm-MAA scan | Dose administrated | Pain during infusion |
| 1 | 60 | Colorectal | FOLFOX | Yes | Common hepatic artery | No | 75% | Yes |
| 2 | 39 | Pancreatic NET | No | No | Left hepatic artery | No | 100% | No |
| 3 | 53 | Ileal carcinoid | No | Yes | Proper hepatic artery | No | 100% | Yes |
| 4 | 65 | Cholangiocarcinoma | GEMOX | No | Right and left hepatic artery | No | 75% | Yes |
| 5 | 54 | Renal | No | Yes | Proper hepatic artery | No | 100% | Yes |
| 6 | 48 | Colorectal | No | Yes | Proper hepatic artery | No | 60% | Yes |
99Tcm-MAA scan: 99Tc-radiolabeled macroaggregated albumin; FOLFOX: Folinic acid, fluorouracil and oxaliplatin; GEMOX: Gemcitabine and oxaliplatine; NET: Neuroendocrine tumour.